Early Access — free while we kick the tires
EdgarHawk

Soparkar Peter

CHIEF OPERATING OFFICER

Officer
1 filing analyzed · 1 company · Latest 2025-12-08

Companies

Company Buys Sells Direction
Adverum Biotechnologies, Inc. ADVM 1 0 Net buying

Activity

December 2025
high
Buy
50,000 shares
$211,000
Significance 6/10

COO Soparkar buys 50,000 shares of ADVM at $4.22 for $211,000, increasing stake 165.6% amid losses of $-47.7M and -72.2% revenue decline

Soparkar Peter, Chief Operating Officer, purchased 50,000 shares at $4.22 per share on 2025-12-05, increasing his holdings from 30,189 to 80,189 shares (a 165.6% increase in his position size). The purchase occurs in a context of significant financial deterioration: the company reported net income of $-47.7M, annual revenue declined -72.2% year-over-year, and the latest quarterly revenue was $0.00. The stock trades -31.1% below its 52-week high of $6.33, placing it in the lower half of its 52-week range. A senior executive's material commitment of capital into the company at depressed valuations could reflect confidence in an operational turnaround or correction strategy, yet the sharply negative fundamentals and revenue collapse underscore elevated execution risk. Investors should scrutinize whether the COO's accumulation signals conviction in a recovery thesis or reflects an asymmetric bet on a distressed turnaround scenario.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access